About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The Microbiology research group of the Vall d'Hebron Research Institute (VHIR) focuses on the study of microbiological aspects —in basic, translational and clinical research— that could improve the outcome of patients with infectious diseases.
Our priority research areas are:
We actively collaborate with other microbiology laboratories, health services, national and international centres and organizations, as well as with the different research networks of the Carlos III Health Institute in Spain.
In addition, we carry out an important activity in the surveillance of the genotypic and phenotypic evolution of microorganisms present in the community in terms of their virulence, transmissibility, antigenic escape and antimicrobial resistance, in collaboration with public administrations, both at the national and international level.
PMID: 31855546 Journal: EMERGING INFECTIOUS DISEASES Year: 2020 Reference: Emerg Infect Dis. 2020 Jan;26(1):134-137. doi: 10.3201/eid2601.190778. Impact factor: 6.259 Publication type: Paper in international publication Authors: Bosch, Albert, Guix, Susana, Fuentes, Cristina, Pinto, Rosa M, Blanco, Albert, Sabria, Aurora, Anfruns-Estrada, Eduard, Garrido, Virginia Rodriguez, Alonso, Manuel, Bartolome, Rosa et al. DOI: 10.3201/eid2601.190778
PMID: 31674901 Journal: EMERGING INFECTIOUS DISEASES Year: 2020 Reference: Emerg Infect Dis. 2020 Jan;26(1):150-153. doi: 10.3201/eid2601.181685. Epub 2020 Jan 17. Impact factor: 6.259 Publication type: Paper in international publication Authors: Salvador, Fernando, Sanchez-Montalva, Adrian, Espasa, Mateu, Molina, Daniel, de Ory, Fernando, Sanchez-Seco, M Paz, Molina, Israel, Diaz-Lagares, Candido, Martinez, Miguel J, Pumarola, Tomas et al. DOI: 10.3201/eid2601.181685
PMID: 31530462 Journal: JOURNAL OF ARTHROPLASTY Year: 2020 Reference: J Arthroplasty. 2020 Jan;35(1):247-254. doi: 10.1016/j.arth.2019.07.043. Epub 2019 Aug 19. Impact factor: 3.709 Publication type: Paper in international publication Authors: Corro, Sebastian, Vicente, Matias, Rodriguez-Pardo, Dolors, Pigrau, Carles, Lung, Mayli, Corona, Pablo S et al. DOI: 10.1016/j.arth.2019.07.043
PMID: 30530096 Journal: JOURNAL OF CLINICAL VIROLOGY Year: 2019 Reference: J Clin Virol. 2019 Jan;110:29-35. doi: 10.1016/j.jcv.2018.11.004. Epub 2018 Nov 30. Impact factor: 3.02 Publication type: Paper in international publication Authors: Pumarola, Tomas, Andres, Cristina, Vila, Jorgina, Gimferrer, Laura, Pinana, Maria, Esperalba, Juliana, Codina, Maria Gema, Barnes, Meritxell, Martin, Maria Carmen, Fuentes, Francisco et al. DOI: 10.1016/j.jcv.2018.11.004
PMID: 30391324 Journal: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES Year: 2019 Reference: Int J Infect Dis. 2019 Jan;78:103-106. doi: 10.1016/j.ijid.2018.10.014. Epub 2018 Oct 25. Impact factor: 3.538 Publication type: Paper in international publication Authors: Horcajada, J P, Grau, S, Pascual, J, Monge, I, Crespo, M, Veliz Espinosa, G, Montero, M, Mir, M, Sulleiro, E, Avalos Esquivel, J L et al. DOI: 10.1016/j.ijid.2018.10.014
The new diagnostic method, designed for use in endemic regions, combines a mobile application with a low-cost robotic microscope.
The European network EUPertStrain celebrates its annual meeting, focused on the study of the evolution of Bordetella pertussis, the bacterium responsible for this disease that can be very serious in children under one year.
The Vall d'Hebron work has shown that people vaccinated with Pfizer or Moderna have specific memory T lymphocytes against SARS-CoV-2 in the lung months after vaccination.
